Former deputy chief medical officer for England, Prof Sir Jonathan Van-Tam, who is pro-vice-chancellor for the Faculty of Medicine and Health Sciences at the University of Nottingham and study co-author, said: “While molnupiravir was originally found to work well to reduce hospitalisation in patients with Covid, these were unvaccinated patients. Source link
The European Union’s drug regulator on Thursday conditionally approved the use of Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after … Read more
The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday. The ICMR’s National Task Force for COVID-19 has decided against including antiviral drug Molnupiravir in the Clinical Management Protocol for COVID-19 as of … Read more
Molflu is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high caseload of Covid-19. Dr Reddy’s Laboratories will be launching its Molnupiravir oral anti-viral drug for Covid-19 under the brand name Molflu across the country. Molflu is expected to be available from early next … Read more
The UK clearance to molnupiravir, and the results shown by Pfizer’s drug, has given hope that it would pave the way for more effective management of Covid-19 in all the countries (Photo: Reuters) The UK drug regulator has announced that it has given a heads up to first oral antiviral for covid-19 treatment on Thursday. … Read more
Robin Foster, HealthDay Reporter FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection … Read more
As per the agreement, the pharma majors will jointly sponsor, supervise and monitor the clinical trial in India. Five major pharma companies of India have entered into a collaboration for the clinical trial of oral anti-viral drug Molnupiravir for the treatment of mild COVID-19. Indian pharmaceutical companies that have joined hands for this are – … Read more
Representative image After an outcry for remdesivir, there is now yet another experimental anti-viral drug – Molnupiravir to deal with COVID patients. Hyderabad-headquartered Natco Pharma on Monday, April 26th, disclosed to the bourses that it has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir … Read more